Over the past years additional functions have emerged for mismatch repair proteins. The first was the involvement of mismatch repair proteins with homologous DNA recombination, one of the pathways that repair DNA double-strand breaks. A key intermediate in this repair process is heteroduplex joint formation between the ends of the broken molecule and an intact, homologous partner (Fig. 3Fig. 3). During meiosis, the specialized MutS-homologous dimer MSH4–MSH5 stimulates the induction of crossovers at joints between homologous autosomes, in conjunction with the MutL homologues (Fig. 3Fig. 3a). Polymorphisms, commonly present in homologous autosomes, are apparent as mismatches within the joints. MSH2–MSH6, together with the MutL homologues, corrects these mismatches in a process called gene conversion (Fig. 3Fig. 3a,b). Double strand breaks in somatic cells, such as those induced by X-rays, may result in translocations or in loss of genetic information when homologous recombination takes place between nonidentical sequences, such as pseudogenes or homologous autosomes, rather than between identical sister chromatids. In these cells, mismatch repair generally does not perform gene conversion, but instead antagonizes mismatch-containing heteroduplex joints in a process called anti-recombination (Fig. 3Fig. 3c). Absence of mismatch repair, therefore, allows crossover between diverged sequences. As an example, crosses between E. coli and mismatch-repair-deficient Salmonella typhimurium cells result in interspecies hybrids, because crossovers between the 20% diverged genomes now proceed unrestrained.Fig. 3Roles of mismatch repair in determining the outcome of homologous DNA recombination. Top: both ends of each strand of a broken, gapped, DNA molecule (gray backbone) form a heteroduplex junction with a homologous DNA molecule (orange backbone), each consisting of two heteroduplex joints. Note that this represents a simplification of the Holliday model. Sequence divergences between the recombining molecules are apparent as mismatches (M). Mismatch repair proteins can determine the outcome of recombination in three ways: (a) crossover, resulting in an exchange of flanking DNA. This generally is accompanied by repair of the mismatch (‘gene conversion’, indicated by CM). (b) Gene conversion without crossover. (c) Anti-recombination by mismatch repair proteins in somatic cells results in reversion of mismatch-containing heteroduplexes.View Large Image | View Hi-Res Image | Download PowerPoint SlideIn mammalian cells, mismatch repair is involved in triggering apoptosis induced by certain DNA damaging agents. The best examples are agents that methylate the O6 position of guanosine residues, including certain carcinostatic drugs. Wild-type cells are extremely sensitive to these drugs, as incorporation of either C or T opposite O6Me–G residues triggers mismatch-repair-dependent excision. However, resynthesis introduces the same ‘mismatch’, resulting in futile cycles of mismatch repair that ultimately result in apoptosis. An alternative explanation for the mismatch repair dependence of the toxicity of these agents is provided by the similarity of MSH2–MSH6 to Ras nucleotide exchange factors that are active in a GTP-bound form and inactive in a GDP-bound form. MSH2–MSH6, binding to the methylated mispair, exchanges ATP for ADP and might directly signal to downstream effectors of apoptosis. Supporting this model is the detection of mismatch repair proteins in the so-called BRCA1-associated genome surveillance complex, implicated in signaling of DNA damage to cell cycle regulators.Mismatch repair proteins are implicated in several other DNA repair processes, including repair of oxidative nucleotide damage in the transcribed strand of genes, in repair of DNA crosslinks, and in the processing of DNA ends during the single-strand annealing pathway of double strand break repair. All these seemingly diverse activities justify the assignment to mismatch repair of the honorary title ‘Caretaker of our Genome’.